Medistim ASASTU:MD1 +1.25%88 OCF Yield % is 4.26 as of Jul. 03, 2026, which is 42% above its 10-year median of 2.99. GuruFocus rates STU:MD1 with a GF Score™ of 88/100 and a GF Value™ of €22.51. The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Medistim ASA ranks better than 62.06% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medistim ASA's OCF Yield % or its related term are showing as below:
STU:MD1'
s OCF Yield % Range Over the Past 10 Years
Min: 1.06 Med: 2.99 Max: 5.95
Current: 4.26
During the past 13 years, the highest OCF Yield % of Medistim ASA was 5.95%. The lowest was 1.06%. And the median was 2.99%.
STU:MD1's OCF Yield % is ranked better than 62.06% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs STU:MD1: 4.26
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medistim ASA OCF Yield % Related Terms
Medistim ASA OCF Yield % Historical Data
* Premium members only.
The historical data trend for Medistim ASA's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medistim ASA's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Medistim ASA's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (STU:MD1) has a OCF Yield % of 4.26 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medistim ASA and its competitors. This is 42% above median its historical median of 2.99. Over the past decade, Medistim ASA's OCF Yield % has ranged from 1.06 to 5.95. According to the industry distribution chart, Medistim ASA ranks #324 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 37.9%.
Is Medistim ASA's OCF Yield % too high?
Medistim ASA's current OCF Yield % of 4.26 is 42% above median its 10-year median of 2.99. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 5.95. The Medical Devices & Instruments industry median OCF Yield % is 1.68. Medistim ASA's value of 4.26 is 153.6% above this industry median. Based on the distribution chart, Medistim ASA ranks #324 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medistim ASA has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #324 out of 854 companies for OCF Yield %. This puts Medistim ASA in the upper half of its industry. The industry median OCF Yield % is 1.68. Medistim ASA's value of 4.26 is 153.6% above this benchmark. Historically, Medistim ASA's own OCF Yield % has ranged from 1.06 to 5.95 over the past decade. While the company's 10-year median is 2.99 vs. the industry median of 1.68, Medistim ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.68, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current OCF Yield % of 4.26 is 153.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current OCF Yield % is 4.26, which is 42% above median its own 10-year median of 2.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current OCF Yield % of 4.26. The stock's GF Value™ is €22.51, compared to a current price of €20.20 — trading 10.3% below its estimated fair value. The current OCF Yield % is 4.26, which is 42% above median its 10-year median of 2.99 and 153.6% above the Medical Devices & Instruments industry median of 1.68. Medistim ASA's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current OCF Yield % is 4.26 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (STU:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €20.20 is trading 10.3% below its estimated GF Value™ of €22.51.
Key valuation signals for STU:MD1:
OCF Yield %: 4.26 (42% above median its 10-year median of 2.99)
GF Value™: €22.51 vs. price of €20.20 (10.3% below fair value)
Industry Position: 153.6% above the Medical Devices & Instruments median (#324 of 854)
No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
88GF Score
Get the complete analysis for STU:MD1
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MD1 has been successfully added to your 
